Single-cell Omics Market - By Product Type (Genomics, Transcriptomics, Proteomics, Metabolomics), Application (Oncology, Cell Biology, Neurology, Immunology), End-user (Pharma & Biotech Companies, Hospital Laboratories), Global Forecast (2023 – 2032)
Published Date: July - 2024 | Publisher: MIR | No of Pages: 240 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationSingle-cell Omics Market - By Product Type (Genomics, Transcriptomics, Proteomics, Metabolomics), Application (Oncology, Cell Biology, Neurology, Immunology), End-user (Pharma & Biotech Companies, Hospital Laboratories), Global Forecast (2023 – 2032)
Single-cell Omics Market Size
Single-cell Omics Market size accounted for USD 2.4 billion in 2022 and is estimated to grow at 20.2% to reach USD 15.5 billion by 2032. The escalating R&D investments in single-cell analysis research and rising funding programs serve as a pivotal growth driver for the market.
For instance, in November 2022, the Texas A&M University System has received a USD 1.19 million grant from the National Institutes of Health (NIH) to leverage single-cell sequencing technology. This surge in investment is propelled by the profound potential of single-cell omics technologies to revolutionize drug discovery, development, and personalized medicine. Such increasing investment in single-cell analysis research is anticipated to boost the market progress.
| Report Attribute | Details |
|---|---|
| Base Year | 2022 |
| Single-cell Omics Market Size in 2022 | USD 2.4 Billion |
| Forecast Period | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR | 20.2% |
| 2032 Value Projection | USD 15.5 Billion |
| Historical Data for | 2018 to 2022 |
| No. of Pages | 150 |
| Tables, Charts & Figures | 208 |
| Segments covered | Product Type, Application, End-user, and Region |
| Growth Drivers |
|
| Pitfalls & Challenges |
|
The market refers to the segment of the biotechnology and life sciences industry that encompasses the development, production, and commercialization of technologies, tools, products, and services designed to study the molecular characteristics of individual cells at various omics levels.
COVID-19 Impact
When the COVID-19 pandemic hit, it was a wake-up call for researchers. They needed powerful tools to understand this mysterious virus and its impact on our bodies. And that's where single-cell omics technologies stepped up. These technologies allowed scientists to dive deep into the biology of COVID-19. They could see how our immune system fought the virus, identify early warning signs, and uncover the inner workings of the disease. This knowledge was crucial for developing effective treatments and vaccines. Plus, the pandemic pushed single-cell omics research into overdrive. Scientists and companies invested heavily in making these technologies better, faster, and more user-friendly. This meant more researchers had access to these powerful tools, which led to even more discoveries. All of these factors combined are like rocket fuel for the single-cell omics market. As we continue to face health challenges, these technologies will be essential for unlocking new treatments and saving lives.
Single-cell Omics Market Trends
Cancer is becoming more common, which is a very sad reality. Experts predict that in the United States alone, around 1.9 million people will be diagnosed with cancer this year, and over 600,000 will lose their lives to this terrible disease. In Canada, it's estimated that almost half of the population will develop cancer at some point in their lives, and about a quarter will eventually die from it. As cancer becomes more prevalent, we're facing a big challenge. Traditional treatments often struggle to keep up with the different ways that cancer can show up. But there's a new approach called single-cell omics that could change the game. It lets us study each cell in a tumor individually, which is a huge step forward in creating personalized treatments that target each patient's unique cancer.
Single-cell Omics Industry Restraint
A significant market restraint for the single-cell omics market is the high cost associated with single-cell analysis. While the potential insights and benefits provided by single-cell omics technologies are substantial, the expenses tied to implementing and conducting single-cell analyses can be significant barriers for widespread adoption. The costs encompass various aspects, including acquiring specialized instrumentation, purchasing reagents, maintaining the equipment, and investing in skilled personnel capable of executing complex analyses and data interpretation. These financial considerations can pose challenges for smaller research institutions, academic labs, and startups with limited resource, thereby hampering the market demand.
Single-cell Omics Market Analysis
When it comes to studying cells at the individual level, there are different ways to do it. These methods are divided into four categoriesgenomics, proteomics, metabolomics, and transcriptomics. In 2022, the genomics category was the most popular, accounting for about 43% of the market. This is because genomics helps researchers understand the genetic makeup of individual cells. This is helpful because it can reveal differences that would be missed if you looked at a group of cells as a whole. Genomics can also help us learn about rare cell types, groups of cells that are genetically similar, and tiny genetic changes that can have a big impact on things like cancer and development. These benefits are expected to help the genomics market continue to grow in the years to come.
When it comes to the single-cell omics industry, different areas it's used in include cancer research, studying how cells work, brain science, understanding the immune system, and more. Cancer research is the biggest area, making up over half of the industry's sales in 2022. That's because cancer is becoming more common, scientists are getting better at looking at single cells, and special tools are being used to study how cancer grows. Looking at the molecules in cells, especially in cancer cells, is also becoming more popular. This helps scientists find cancer cells more easily and accurately. Researchers are also using single-cell technologies in all sorts of ways, like studying genes, RNA, proteins, and molecules in cells. They're using this to learn more about how cells work and how diseases develop.
Who's using this cutting-edge technology called single-cell omics? Well, it's popular among universities and research centers that are always pushing the boundaries of knowledge. Drug companies and biotech firms are also huge fans, using it to develop new treatments and understand diseases better. Hospitals and labs are jumping on the bandwagon too, using it to diagnose and monitor illnesses more precisely. But guess what? The universities and research centers are leading the pack, with a projected 20% growth rate over the next few years. Why? Because they're constantly looking for new ways to understand cells and advance science. For example, a company called Singular Genomics Systems recently unveiled new tools to make single-cell sequencing even more powerful. And all these efforts are fueling the growth of the market. Plus, with more and more researchers diving into the world of cells, the market is set to skyrocket. They're exploring new applications all the time, unlocking secrets that will pave the way for better treatments, cures, and a deeper understanding of life itself.
The single-cell omics market in North America is thriving! It made up a whopping 47% of the global market in 2022 and is expected to keep growing rapidly in the coming years. Why is North America leading the way? It's a hotbed for science and technology, making it perfect for developing and using these cutting-edge techniques. Plus, there are a lot of companies in the region that are investing in single-cell omics. This technology is perfect for personalized medicine because it can tell us a lot about individual cells. So, it's being used more and more in clinical research and diagnostics. And the government is supporting this innovation with funding and regulations. All of this is helping to make North America a leader in the single-cell omics field.
Single-cell Omics Market Share
Major market players operating in the single-cell omics market include
- CELLENION
- PerkinElmer Inc.
- 10x Genomics
- ANGLE plc
- Illumina, Inc.
- Bio-Rad Laboratories, Inc.
These industry players majorly adopt various strategies including collaborations, acquisitions, mergers, and partnerships to create a global footprint and sustain market competition.
Single-cell Omics Industry News
- In April 2023, Fulgent Genetics launched Mission Bio platform to broaden accessibility of single-cell multi-omics for drug development and clinical research. This strategy helped the company to create new opportunities for the expansion of single-cell multi-omics in the field of drug development and research.
- In June 2021, SCIENION and Cellenion launched its cellenCHIP 384 for single cell omics sample preparation, introducing it as the integral consumable in the new cellenCHIP 384 – 3’RNA-seq kit for scalable, nanoliter volume library preparation of single cells. This strategy helped the company to expands their portfolio for single cell analytics.
The single-cell omics market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032, for the following segments
Click here to Buy Section of this Report
By Product Type
- Single-cell genomics
- Single-cell transcriptomics
- Single-cell proteomics
- Single-cell metabolomics
By Application
- Oncology
- Cell biology
- Neurology
- Immunology
- Other applications
By End-user
- Academic and research organizations
- Pharmaceutical & biotechnology companies
- Hospital and diagnostic laboratories
- Other end-users
The above information is provided for the following regions and countries
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- South Africa
- Saudi Arabia
- Rest of Middle East & Africa
Related Reports
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy